Bausch Health Co. Inc. (BHC) Q4 Revenue Tops Views, Guidance Misses at Mid-Point

Bausch Health Co. Inc. (NYSE: BHC) reported Q4 EPS of ($0.98), may not compare to the analyst estimate of $0.84. Revenue for the quarter came in at $2.12 billion versus the consensus estimate of $2.08 billion.

GUIDANCE:

Bausch Health Co. Inc. sees FY2019 revenue of $8.3-8.5 billion, versus the consensus of $8.49 billion.

For earnings history and earnings-related data on Bausch Health Co. Inc. (BHC) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Worthington Enterprises raises dividend 5%, adds board member